Cargando…
Fecal microbiome differs between patients with systemic sclerosis with and without small intestinal bacterial overgrowth
INTRODUCTION: Gastrointestinal manifestations of systemic sclerosis affect up to 90% of patients, with symptoms including diarrhea and constipation. Small intestinal bacterial overgrowth is a condition associated with increased numbers of pathogenic bacteria in the small bowel. While currently unkno...
Autores principales: | Levin, Daniel, De Palma, Giada, Zou, Hannah, Bazzaz, Ava Hadi Zadeh, Verdu, Elena, Baker, Barbara, Pinto-Sanchez, Maria Ines, Khalidi, Nader, Larché, Maggie J, Beattie, Karen A., Bercik, Premysl |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8922657/ https://www.ncbi.nlm.nih.gov/pubmed/35382497 http://dx.doi.org/10.1177/23971983211032808 |
Ejemplares similares
-
Alterations in fecal β-defensin-3 secretion as a marker of instability of the gut microbiota
por: Saqib, Zarwa, et al.
Publicado: (2023) -
Diet–microbial cross–talk underlying increased visceral perception
por: De Palma, Giada, et al.
Publicado: (2023) -
T192. THE GUT MICROBIOME IN SCHIZOPHRENIA AND ANTIPSYCHOTIC INDUCED METABOLIC DYSFUNCTION
por: Kanji, Sarah, et al.
Publicado: (2018) -
Infliximab therapy in refractory sarcoidosis: a multicenter real-world analysis
por: Sakkat, Abdullah, et al.
Publicado: (2022) -
Percutaneous endoscopic cecostomy for management of Ogilvie’s syndrome: a case series and literature review with an update on current guidelines (with video)
por: Vanek, Petr, et al.
Publicado: (2023)